bionlp-st-ge-2016-spacy-parsed Home  

PMC:1942070 / 8417-8805 JSONTXT 17 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T4516 0-2 IN denotes As
T4517 3-8 VBN denotes shown
T4518 9-11 IN denotes in
T4519 12-16 NNP denotes Fig.
T4520 17-19 NNP denotes 2B
T4521 19-20 , denotes ,
T4522 21-25 NN denotes loss
T4523 26-28 IN denotes of
T4524 29-35 CD denotes PKD1/3
T4525 36-46 NN denotes expression
T4526 47-50 VBD denotes had
T4527 51-53 DT denotes no
T4528 54-65 JJ denotes significant
T4529 66-72 NN denotes impact
T4530 73-75 IN denotes on
T4531 76-79 DT denotes the
T4532 80-88 NN denotes survival
T4533 89-91 IN denotes of
T4534 92-96 NNP denotes DT40
T4535 97-98 NNP denotes B
T4536 99-104 NNS denotes cells
T4537 105-107 IN denotes in
T4538 108-116 NN denotes response
T4539 117-119 TO denotes to
T4540 120-133 JJ denotes mitochondrial
T4541 134-140 NN denotes stress
T4542 141-148 NNS denotes stimuli
T4543 149-150 -LRB- denotes (
T4544 150-154 CD denotes H2O2
T4545 155-157 CC denotes or
T4546 158-163 NN denotes serum
T4547 164-175 NN denotes deprivation
T4548 175-176 -RRB- denotes )
T4549 176-177 : denotes ;
T4550 178-181 NNP denotes DNA
T4551 182-190 VBG denotes damaging
T4552 191-197 NNS denotes agents
T4553 198-199 -LRB- denotes (
T4554 199-208 NN denotes etoposide
T4555 209-211 CC denotes or
T4556 212-223 NN denotes doxorubicin
T4557 223-224 -RRB- denotes )
T4558 224-225 : denotes ;
T4559 226-228 NNP denotes ER
T4560 229-236 NN denotes pathway
T4561 237-243 NN denotes stress
T4562 244-247 JJ denotes due
T4563 248-250 TO denotes to
T4564 251-258 NN denotes calcium
T4565 259-267 NN denotes overload
T4566 268-269 -LRB- denotes (
T4567 269-281 NN denotes thapsigargin
T4568 281-282 -RRB- denotes )
T4569 283-285 CC denotes or
T4570 286-295 VBG denotes following
T4571 296-305 JJ denotes prolonged
T4572 306-315 NN denotes treatment
T4573 316-320 IN denotes with
T4574 321-328 NN denotes phorbol
T4575 329-335 NNS denotes esters
T4576 336-338 CC denotes or
T4577 339-351 NNP denotes Trichostatin
T4578 352-353 NNP denotes A
T4579 353-354 , denotes ,
T4580 355-357 DT denotes an
T4581 358-367 NN denotes inhibitor
T4582 368-370 IN denotes of
T4583 371-376 NN denotes class
T4584 377-381 NNP denotes I/II
T4585 382-387 NNP denotes HDACs
T4586 387-388 . denotes .
R3715 T4516 T4517 mark As,shown
R3716 T4517 T4526 advcl shown,had
R3717 T4518 T4517 prep in,shown
R3718 T4519 T4520 compound Fig.,2B
R3719 T4520 T4518 pobj 2B,in
R3720 T4521 T4520 punct ",",2B
R3721 T4522 T4520 appos loss,2B
R3722 T4523 T4522 prep of,loss
R3723 T4524 T4525 nummod PKD1/3,expression
R3724 T4525 T4523 pobj expression,of
R3725 T4526 T4526 ROOT had,had
R3726 T4527 T4529 det no,impact
R3727 T4528 T4529 amod significant,impact
R3728 T4529 T4526 dobj impact,had
R3729 T4530 T4529 prep on,impact
R3730 T4531 T4532 det the,survival
R3731 T4532 T4530 pobj survival,on
R3732 T4533 T4532 prep of,survival
R3733 T4534 T4535 compound DT40,B
R3734 T4535 T4536 compound B,cells
R3735 T4536 T4533 pobj cells,of
R3736 T4537 T4526 prep in,had
R3737 T4538 T4537 pobj response,in
R3738 T4539 T4538 prep to,response
R3739 T4540 T4542 amod mitochondrial,stimuli
R3740 T4541 T4542 compound stress,stimuli
R3741 T4542 T4539 pobj stimuli,to
R3742 T4543 T4542 punct (,stimuli
R3743 T4544 T4542 appos H2O2,stimuli
R3744 T4545 T4544 cc or,H2O2
R3745 T4546 T4547 compound serum,deprivation
R3746 T4547 T4544 conj deprivation,H2O2
R3747 T4548 T4542 punct ),stimuli
R3748 T4549 T4542 punct ;,stimuli
R3749 T4550 T4552 amod DNA,agents
R3750 T4551 T4552 amod damaging,agents
R3751 T4552 T4542 conj agents,stimuli
R3752 T4553 T4552 punct (,agents
R3753 T4554 T4552 appos etoposide,agents
R3754 T4555 T4554 cc or,etoposide
R3755 T4556 T4554 conj doxorubicin,etoposide
R3756 T4557 T4552 punct ),agents
R3757 T4558 T4526 punct ;,had
R3758 T4559 T4561 compound ER,stress
R3759 T4560 T4561 compound pathway,stress
R3760 T4561 T4570 nsubj stress,following
R3761 T4562 T4561 amod due,stress
R3762 T4563 T4562 pcomp to,due
R3763 T4564 T4565 compound calcium,overload
R3764 T4565 T4562 pobj overload,due
R3765 T4566 T4567 punct (,thapsigargin
R3766 T4567 T4565 appos thapsigargin,overload
R3767 T4568 T4567 punct ),thapsigargin
R3768 T4569 T4565 cc or,overload
R3769 T4570 T4526 advcl following,had
R3770 T4571 T4572 amod prolonged,treatment
R3771 T4572 T4570 dobj treatment,following
R3772 T4573 T4572 prep with,treatment
R3773 T4574 T4575 compound phorbol,esters
R3774 T4575 T4573 pobj esters,with
R3775 T4576 T4575 cc or,esters
R3776 T4577 T4578 compound Trichostatin,A
R3777 T4578 T4575 conj A,esters
R3778 T4579 T4578 punct ",",A
R3779 T4580 T4581 det an,inhibitor
R3780 T4581 T4578 appos inhibitor,A
R3781 T4582 T4581 prep of,inhibitor
R3782 T4583 T4585 compound class,HDACs
R3783 T4584 T4585 compound I/II,HDACs
R3784 T4585 T4582 pobj HDACs,of
R3785 T4586 T4526 punct .,had